The risk or severity of adverse effects can be increased when morphine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when buspirone is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when reserpine is combined with secobarbital.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with topiramate.


The risk or severity of adverse effects can be increased when thiopental is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when alprazolam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when morphine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when thiothixene is combined with Pizotifen.


The risk or severity of adverse effects can be increased when buspirone is combined with zaleplon.


The risk or severity of adverse effects can be increased when buspirone is combined with mepivacaine.


The risk or severity of adverse effects can be increased when lorazepam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when buspirone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when amiodarone is combined with cilazapril.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with Butylscopolamine.


The risk or severity of adverse effects can be increased when Tramadol is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Tasimelteon is combined with duloxetine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with penbutolol.


The risk or severity of adverse effects can be increased when Tasimelteon is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Telmisartan.


The risk or severity of adverse effects can be increased when salicylamide is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when halothane is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when Salsalate is combined with alclofenac.


The risk or severity of adverse effects can be increased when suprofen is combined with betamethasone.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with nitric oxide.


The risk or severity of adverse effects can be increased when nitric oxide is combined with isradipine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when glutethimide is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Olmesartan.


The risk or severity of adverse effects can be increased when clidinium is combined with Ramelteon.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with maprotiline.


The risk or severity of adverse effects can be increased when glutethimide is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when oxaprozin is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when brotizolam is combined with flunarizine.


The risk or severity of adverse effects can be increased when lorazepam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when ganciclovir is combined with zalcitabine.


The risk or severity of adverse effects can be increased when loxapine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when barnidipine is combined with quetiapine.


The risk or severity of adverse effects can be increased when clidinium is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Carbetocin is combined with acebutolol.


The risk or severity of adverse effects can be increased when Ephedrine is combined with nylidrin.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with captopril.


The risk or severity of adverse effects can be increased when loxapine is combined with prilocaine.


The risk or severity of adverse effects can be increased when procaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Phenelzine is combined with lithium ion.


The risk or severity of adverse effects can be increased when procyclidine is combined with HEROIN.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Radium-223 chloride.


The risk or severity of adverse effects can be increased when pentazocine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when hydromorphone is combined with quetiapine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when pentazocine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with ketamine.


The risk or severity of adverse effects can be increased when cocaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when rasagiline is combined with linezolid.


The risk or severity of adverse effects can be increased when nadolol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with prednisone.


The risk or severity of adverse effects can be increased when fenoprofen is combined with azelastine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when trazodone is combined with procaine.


The risk or severity of adverse effects can be increased when floctafenine is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when metoclopramide is combined with venlafaxine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Remoxipride.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with loxapine.


The risk or severity of adverse effects can be increased when olanzapine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when diazepam is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with diflorasone.


The risk or severity of adverse effects can be increased when morphine is combined with nifedipine.


The risk or severity of adverse effects can be increased when morphine is combined with meprobamate.


The risk or severity of adverse effects can be increased when morphine is combined with timolol.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with sertraline.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when pancuronium is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with isradipine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Olmesartan.


The risk or severity of adverse effects can be increased when fenoprofen is combined with ketoprofen.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when quetiapine is combined with penbutolol.


The risk or severity of adverse effects can be increased when alprazolam is combined with clozapine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when temozolomide is combined with leflunomide.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with promethazine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with clonazepam.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Perospirone.


The risk or severity of adverse effects can be increased when ILOPROST is combined with D-mannitol.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with netilmicin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with flurazepam.


The risk or severity of adverse effects can be increased when ethotoin is combined with venlafaxine.


The risk or severity of adverse effects can be increased when amifostine is combined with quetiapine.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Pentolinium.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Tramadol.


The risk or severity of adverse effects can be increased when levorphanol is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with prazosin.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with loratadine.


The risk or severity of adverse effects can be increased when suprofen is combined with Apremilast.


The risk or severity of adverse effects can be increased when lisinopril is combined with Masoprocol.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when quinapril is combined with floctafenine.


The risk or severity of adverse effects can be increased when amifostine is combined with nifedipine.


The risk or severity of adverse effects can be increased when reserpine is combined with indapamide.


The risk or severity of adverse effects can be increased when amifostine is combined with papaverine.


The risk or severity of adverse effects can be increased when prilocaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when HEROIN is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when HEROIN is combined with moclobemide.


The risk or severity of adverse effects can be increased when levorphanol is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when Masoprocol is combined with aspirin.


The risk or severity of adverse effects can be increased when Posaconazole is combined with vinorelbine.


The risk or severity of adverse effects can be increased when biperiden is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when clozapine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when levorphanol is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when levorphanol is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when benztropine is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when ILOPROST is combined with morphine.


The risk or severity of adverse effects can be increased when ILOPROST is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when nicardipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when tolmetin is combined with estrone.


The risk or severity of adverse effects can be increased when doxazosin is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when METHSUXIMIDE is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when nabumetone is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when desoximetasone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when Tramadol is combined with Remoxipride.


The risk or severity of adverse effects can be increased when trazodone is combined with HEROIN.


The risk or severity of adverse effects can be increased when dexamethasone is combined with mefloquine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when floctafenine is combined with alclofenac.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when diltiazem is combined with felodipine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with glutethimide.


The risk or severity of adverse effects can be increased when ibuprofen is combined with triamcinolone.


The risk or severity of adverse effects can be increased when pramipexole is combined with trandolapril.


The risk or severity of adverse effects can be increased when diltiazem is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when diazepam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when rasagiline is combined with Paliperidone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with etodolac.


The risk or severity of adverse effects can be increased when tolazoline is combined with bumetanide.


The risk or severity of adverse effects can be increased when Flupentixol is combined with efavirenz.


The risk or severity of adverse effects can be increased when tolazoline is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when sulfanilamide is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with captopril.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with acebutolol.


The risk or severity of adverse effects can be increased when oxycodone is combined with quetiapine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when loxapine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when thiopental is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with clomipramine.


The risk or severity of adverse effects can be increased when minoxidil is combined with mecamylamine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when tiagabine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with quetiapine.


The risk or severity of adverse effects can be increased when triamterene is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when triamterene is combined with felodipine.


The risk or severity of adverse effects can be increased when docetaxel is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when methscopolamine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when hexetidine is combined with Pinaverium.


The risk or severity of adverse effects can be increased when triamterene is combined with irbesartan.


The risk or severity of adverse effects can be increased when docetaxel is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when Bretylium is combined with cilazapril.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with metolazone.


The risk or severity of adverse effects can be increased when lorazepam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with minoxidil.


The risk or severity of adverse effects can be increased when fenoldopam is combined with papaverine.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with malathion.


The risk or severity of adverse effects can be increased when lorazepam is combined with butorphanol.


The risk or severity of adverse effects can be increased when ketamine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Nabilone is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when Nabilone is combined with metolazone.


The risk or severity of adverse effects can be increased when tetracaine is combined with sertraline.


The risk or severity of adverse effects can be increased when zonisamide is combined with Escitalopram.


The risk or severity of adverse effects can be increased when zonisamide is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when benzoic acid is combined with gabapentin.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Pramocaine.


The risk or severity of adverse effects can be increased when docetaxel is combined with ciprofloxacin.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when docetaxel is combined with Erlotinib.


The risk or severity of adverse effects can be increased when indinavir is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when Masoprocol is combined with fenbufen.


The risk or severity of adverse effects can be increased when dipyridamole is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when docetaxel is combined with toremifene.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with Flibanserin.


The risk or severity of adverse effects can be increased when apomorphine is combined with Rotigotine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with amoxapine.


The risk or severity of adverse effects can be increased when bromazepam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with lisinopril.


The risk or severity of adverse effects can be increased when methadone is combined with butorphanol.


The risk or severity of adverse effects can be increased when Asenapine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Lopinavir is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when nicardipine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Asenapine is combined with HEROIN.


The risk or severity of adverse effects can be increased when Pentolinium is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when losartan is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Varenicline.


The risk or severity of adverse effects can be increased when loxapine is combined with brotizolam.


The risk or severity of adverse effects can be increased when Remoxipride is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when zaleplon is combined with sevoflurane.


The risk or severity of adverse effects can be increased when Naftifine is combined with budesonide.


The risk or severity of adverse effects can be increased when cilnidipine is combined with morphine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when carprofen is combined with leflunomide.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with estazolam.


The risk or severity of adverse effects can be increased when Lurasidone is combined with imipramine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Clobetasone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with dantrolene.


The risk or severity of adverse effects can be increased when Lurasidone is combined with loratadine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when lorazepam is combined with paroxetine.


The risk or severity of adverse effects can be increased when cerulenin is combined with Amrinone.


The risk or severity of adverse effects can be increased when rapamycin is combined with enalapril.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with maprotiline.


The risk or severity of adverse effects can be increased when lorazepam is combined with fludiazepam.


The risk or severity of adverse effects can be increased when alprazolam is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with nalbuphine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with morphine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when Cladribine is combined with clozapine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with butalbital.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when ceritinib is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Perospirone.


The risk or severity of adverse effects can be increased when Naftifine is combined with epirizole.


The risk or severity of adverse effects can be increased when procyclidine is combined with propantheline.


The risk or severity of adverse effects can be increased when pramipexole is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Difenoxin.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with duloxetine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with fluoxetine.


The risk or severity of adverse effects can be increased when proparacaine is combined with amisulpride.


The risk or severity of adverse effects can be increased when Mometasone is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when valsartan is combined with Naftifine.


The risk or severity of adverse effects can be increased when Naftifine is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Propacetamol.


The risk or severity of adverse effects can be increased when sevoflurane is combined with doxepin.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with butamben.


The risk or severity of adverse effects can be increased when sevoflurane is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when itraconazole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when methysergide is combined with isradipine.


The risk or severity of adverse effects can be increased when suprofen is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when furazolidone is combined with bupropion.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Stepronin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with butalbital.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when triazolam is combined with brotizolam.


The risk or severity of adverse effects can be increased when flunisolide is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with halothane.


The risk or severity of adverse effects can be increased when Delavirdine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when triazolam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with terazosin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Conivaptan is combined with timolol.


The risk or severity of adverse effects can be increased when sevoflurane is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when benazepril is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when methylergonovine is combined with vinorelbine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with clozapine.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with decamethonium.


The risk or severity of adverse effects can be increased when haloperidol is combined with tiapride.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with hydralazine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with cetirizine.


The risk or severity of adverse effects can be increased when benazepril is combined with bumetanide.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with protriptyline.


The risk or severity of adverse effects can be increased when salicylamide is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when promazine is combined with proparacaine.


The risk or severity of adverse effects can be increased when Halazepam is combined with primidone.


The risk or severity of adverse effects can be increased when sulpiride is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with desoximetasone.


The risk or severity of adverse effects can be increased when oxycodone is combined with nitrazepam.


The risk or severity of adverse effects can be increased when salicylamide is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with HEROIN.


The risk or severity of adverse effects can be increased when Almotriptan is combined with triflupromazine.


The risk or severity of adverse effects can be increased when D-mannitol is combined with Clevidipine.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with budesonide.


The risk or severity of adverse effects can be increased when propoxyphene is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with duloxetine.


The risk or severity of adverse effects can be increased when indomethacin is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when propoxyphene is combined with levodopa.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with topiramate.


The risk or severity of adverse effects can be increased when isoflurane is combined with losartan.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with trazodone.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when probenecid is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with dexamethasone.


The risk or severity of adverse effects can be increased when vinblastine is combined with mitomycin C.


The risk or severity of adverse effects can be increased when sumatriptan is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when sumatriptan is combined with clomipramine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with dexamethasone.


The risk or severity of adverse effects can be increased when temazepam is combined with clozapine.


The risk or severity of adverse effects can be increased when zotepine is combined with flunarizine.


The risk or severity of adverse effects can be increased when Pizotifen is combined with paroxetine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with loratadine.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when diclofenac is combined with flunisolide.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when MAGNESIUM SULFATE is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Pramocaine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with imipramine.


The risk or severity of adverse effects can be increased when nevirapine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Remoxipride is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when codeine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Remoxipride is combined with prazepam.


The risk or severity of adverse effects can be increased when sulpiride is combined with Difenoxin.


The risk or severity of adverse effects can be increased when trandolapril is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when quetiapine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Torasemide is combined with hydralazine.


The risk or severity of adverse effects can be increased when levorphanol is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Mirabegron.


The risk or severity of adverse effects can be increased when propofol is combined with perphenazine.


The risk or severity of adverse effects can be increased when codeine is combined with dyclonine.


The risk or severity of adverse effects can be increased when Pitavastatin is combined with DAPTOMYCIN.


The risk or severity of adverse effects can be increased when codeine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when amiodarone is combined with phentolamine.


The risk or severity of adverse effects can be increased when amiodarone is combined with furosemide.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Paliperidone.


The risk or severity of adverse effects can be increased when methotrexate is combined with tegafur.


The risk or severity of adverse effects can be increased when salicylamide is combined with fluocinonide.


The risk or severity of adverse effects can be increased when butabarbital is combined with Etidocaine.


The risk or severity of adverse effects can be increased when zaleplon is combined with zonisamide.


The risk or severity of adverse effects can be increased when zaleplon is combined with cocaine.


The risk or severity of adverse effects can be increased when zaleplon is combined with tiagabine.


The risk or severity of adverse effects can be increased when zaleplon is combined with ondansetron.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with diflunisal.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with chlormezanone.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with chlormezanone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with PAMABROM.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with moclobemide.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with phenobarbital.


The risk or severity of adverse effects can be increased when procaine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Halobetasol is combined with Echothiophate.


The risk or severity of adverse effects can be increased when butabarbital is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when triazolam is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when midazolam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Halobetasol is combined with norfloxacin.


The risk or severity of adverse effects can be increased when midazolam is combined with Remoxipride.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with apraclonidine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with Telmisartan.


The risk or severity of adverse effects can be increased when amisulpride is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Metixene is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with carbamazepine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with methyldopa.


The risk or severity of adverse effects can be increased when ketamine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when cilazapril is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when proparacaine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when desipramine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when estazolam is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when proparacaine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Pipamperone.


The risk or severity of adverse effects can be increased when ramipril is combined with Naftifine.


The risk or severity of adverse effects can be increased when benzocaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when dyclonine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Salsalate is combined with haloperidol.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with manidipine.


The risk or severity of adverse effects can be increased when imipramine is combined with dobutamine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with selegiline.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with pancuronium.


The risk or severity of adverse effects can be increased when isoflurane is combined with sevoflurane.


The risk or severity of adverse effects can be increased when isoflurane is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Masoprocol.


The risk or severity of adverse effects can be increased when tolazoline is combined with D-mannitol.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with protriptyline.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with lisinopril.


The risk or severity of adverse effects can be increased when hydromorphone is combined with metolazone.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with cetirizine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when lorazepam is combined with propoxyphene.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when timolol is combined with nisoldipine.


The risk or severity of adverse effects can be increased when pancuronium is combined with topiramate.


The risk or severity of adverse effects can be increased when fludiazepam is combined with zotepine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when quinidine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when dyclonine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when dyclonine is combined with clemastine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with propoxyphene.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with dyclonine.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with metoclopramide.


The risk or severity of adverse effects can be increased when Nepafenac is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with mesalamine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with amcinonide.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with prednisone.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with estrone.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Eplerenone is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with tolmetin.


The risk or severity of adverse effects can be increased when epirizole is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when bepridil is combined with lovastatin.


The risk or severity of adverse effects can be increased when mesalamine is combined with medrysone.


The risk or severity of adverse effects can be increased when brotizolam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with nicotine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Cevimeline.


The risk or severity of adverse effects can be increased when halothane is combined with Eplerenone.


The risk or severity of adverse effects can be increased when imipramine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when halothane is combined with methazolamide.


The risk or severity of adverse effects can be increased when ramipril is combined with betaxolol.


The risk or severity of adverse effects can be increased when halothane is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with felbamate.


The risk or severity of adverse effects can be increased when floctafenine is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when citalopram is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with tiapride.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with clidinium.


The risk or severity of adverse effects can be increased when etodolac is combined with betamethasone.


The risk or severity of adverse effects can be increased when Icatibant is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when minoxidil is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when benzocaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when dantrolene is combined with Escitalopram.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when nalbuphine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Linagliptin.


The risk or severity of adverse effects can be increased when epirizole is combined with Propacetamol.


The risk or severity of adverse effects can be increased when nalbuphine is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when quetiapine is combined with Halazepam.


The risk or severity of adverse effects can be increased when antipyrine is combined with alclometasone.


The risk or severity of adverse effects can be increased when quetiapine is combined with proparacaine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when barnidipine is combined with trandolapril.


The risk or severity of adverse effects can be increased when tretinoin is combined with nimodipine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with selegiline.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when tropicamide is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when butabarbital is combined with fexofenadine.


The risk or severity of adverse effects can be increased when miconazole is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when dyclonine is combined with thiamylal.


The risk or severity of adverse effects can be increased when dyclonine is combined with desipramine.


The risk or severity of adverse effects can be increased when Difenoxin is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when clomipramine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Normethadone is combined with zonisamide.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with Ditazole.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with losartan.


The risk or severity of adverse effects can be increased when Normethadone is combined with tiagabine.


The risk or severity of adverse effects can be increased when Normethadone is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when halothane is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with budesonide.


The risk or severity of adverse effects can be increased when lorazepam is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Rotigotine is combined with tretinoin.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Lurasidone.


The risk or severity of adverse effects can be increased when CALCIUM CHLORIDE is combined with ergocalciferol.


The risk or severity of adverse effects can be increased when benazepril is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when brotizolam is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Torasemide is combined with sotalol.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with topiramate.


The risk or severity of adverse effects can be increased when zolpidem is combined with Escitalopram.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with trandolapril.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when clorazepate is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with clemastine.


The risk or severity of adverse effects can be increased when erythromycin is combined with Flibanserin.


The risk or severity of adverse effects can be increased when tenoxicam is combined with ibuprofen.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with clonidine.


The risk or severity of adverse effects can be increased when clorazepate is combined with bromazepam.


The risk or severity of adverse effects can be increased when proparacaine is combined with tiapride.


The risk or severity of adverse effects can be increased when ketorolac is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when betaxolol is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when perphenazine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with morphine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with papaverine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with formoterol.


The risk or severity of adverse effects can be increased when etodolac is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when moclobemide is combined with isoetharine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with amobarbital.


The risk or severity of adverse effects can be increased when floxuridine is combined with leflunomide.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when rescinnamine is combined with etodolac.


The risk or severity of adverse effects can be increased when gabapentin is combined with Iloperidone.


The risk or severity of adverse effects can be increased when morphine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when zopiclone is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when quinapril is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Tramadol is combined with risperidone.


The risk or severity of adverse effects can be increased when acemetacin is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when rescinnamine is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when Tramadol is combined with meclizine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with diltiazem.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Agomelatine.


The risk or severity of adverse effects can be increased when lithium ion is combined with flunarizine.


The risk or severity of adverse effects can be increased when maprotiline is combined with bromocriptine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when thiamylal is combined with dantrolene.


The risk or severity of adverse effects can be increased when Pipamperone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Butethal is combined with Normethadone.


The risk or severity of adverse effects can be increased when acetazolamide is combined with metformin.


The risk or severity of adverse effects can be increased when methyldopa is combined with terazosin.


The risk or severity of adverse effects can be increased when celecoxib is combined with alclometasone.


The risk or severity of adverse effects can be increased when Micafungin is combined with Pinaverium.


The risk or severity of adverse effects can be increased when oxazepam is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when oxazepam is combined with Butethal.


The risk or severity of adverse effects can be increased when oxazepam is combined with amobarbital.


The risk or severity of adverse effects can be increased when lorazepam is combined with desipramine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Olopatadine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with haloperidol.


The risk or severity of adverse effects can be increased when benzocaine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when amobarbital is combined with clidinium.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when benzocaine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with triflupromazine.


The risk or severity of adverse effects can be increased when tolnaftate is combined with Clevidipine.


The risk or severity of adverse effects can be increased when indomethacin is combined with nimesulide.


The risk or severity of adverse effects can be increased when clonidine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Artemether is combined with dapsone.


The risk or severity of adverse effects can be increased when clidinium is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when aspirin is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when Rufinamide is combined with HEROIN.


The risk or severity of adverse effects can be increased when procyclidine is combined with oxycodone.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when oxybutynin is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when secobarbital is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when oxybutynin is combined with pancuronium.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when thiopental is combined with brotizolam.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with methyldopa.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with Telmisartan.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with apraclonidine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when captopril is combined with oxaprozin.


The risk or severity of adverse effects can be increased when oxiconazole is combined with nisoldipine.


The risk or severity of adverse effects can be increased when diazepam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Trospium is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with topiramate.


The risk or severity of adverse effects can be increased when methylene blue is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when diazepam is combined with amisulpride.


The risk or severity of adverse effects can be increased when Tramadol is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when risperidone is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when acemetacin is combined with Tixocortol.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Olopatadine.


The risk or severity of adverse effects can be increased when clozapine is combined with carvedilol.


The risk or severity of adverse effects can be increased when indomethacin is combined with betamethasone.


The risk or severity of adverse effects can be increased when Propiverine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when prazosin is combined with Eprosartan.


The risk or severity of adverse effects can be increased when nitrendipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Tramadol is combined with promethazine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when epirizole is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when triamterene is combined with Telmisartan.


The risk or severity of adverse effects can be increased when efavirenz is combined with Desloratadine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when zopiclone is combined with meclizine.


The risk or severity of adverse effects can be increased when methadone is combined with scopolamine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Nepafenac.


The risk or severity of adverse effects can be increased when oxymorphone is combined with zonisamide.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with tubocurarine.


The risk or severity of adverse effects can be increased when pergolide is combined with doxorubicin.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with benazepril.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when butamben is combined with maprotiline.


The risk or severity of adverse effects can be increased when Fidaxomicin is combined with simvastatin.


The risk or severity of adverse effects can be increased when pentazocine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when methazolamide is combined with hydralazine.


The risk or severity of adverse effects can be increased when mefloquine is combined with methacholine.


The risk or severity of adverse effects can be increased when pentazocine is combined with methazolamide.


The risk or severity of adverse effects can be increased when diazepam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when pentazocine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with pargyline.


The risk or severity of adverse effects can be increased when Halazepam is combined with glutethimide.


The risk or severity of adverse effects can be increased when alprazolam is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when testosterone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with ketamine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with methazolamide.


The risk or severity of adverse effects can be increased when Clobetasone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when STIRIPENTOL is combined with Milnacipran.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when mepivacaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when probenecid is combined with furosemide.


The risk or severity of adverse effects can be increased when selegiline is combined with mirtazapine.


The risk or severity of adverse effects can be increased when selegiline is combined with timolol.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Flupentixol.


The risk or severity of adverse effects can be increased when methylergonovine is combined with TROLEANDOMYCIN.


The risk or severity of adverse effects can be increased when Telmisartan is combined with lisinopril.


The risk or severity of adverse effects can be increased when pergolide is combined with epinephrine.


The risk or severity of adverse effects can be increased when brimonidine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Pinaverium is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when etodolac is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when temazepam is combined with propoxyphene.


The risk or severity of adverse effects can be increased when temazepam is combined with dyclonine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with acetaminophen.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Milnacipran is combined with thiothixene.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Clofarabine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Olopatadine is combined with diflorasone.


The risk or severity of adverse effects can be increased when chlormezanone is combined with duloxetine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when chlormezanone is combined with fluoxetine.


The risk or severity of adverse effects can be increased when quazepam is combined with meclizine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Deferasirox.


The risk or severity of adverse effects can be increased when topiramate is combined with primidone.


The risk or severity of adverse effects can be increased when Perospirone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when nabumetone is combined with oxaprozin.


The risk or severity of adverse effects can be increased when Isoconazole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with meperidine.


The risk or severity of adverse effects can be increased when irbesartan is combined with alclofenac.


The risk or severity of adverse effects can be increased when barnidipine is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when doxazosin is combined with Telmisartan.


The risk or severity of adverse effects can be increased when triflupromazine is combined with phenytoin.


The risk or severity of adverse effects can be increased when doxazosin is combined with apraclonidine.


The risk or severity of adverse effects can be increased when nicardipine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when enflurane is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when thioridazine is combined with Etomidate.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Escitalopram.


The risk or severity of adverse effects can be increased when clomipramine is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when Tolcapone is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with carvedilol.


The risk or severity of adverse effects can be increased when selegiline is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with primidone.


The risk or severity of adverse effects can be increased when lithium ion is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Melatonin is combined with Retigabine.


The risk or severity of adverse effects can be increased when methadone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with ketamine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when rescinnamine is combined with alclofenac.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Nabilone.


The risk or severity of adverse effects can be increased when codeine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when butorphanol is combined with Eplerenone.


The risk or severity of adverse effects can be increased when butorphanol is combined with methazolamide.


The risk or severity of adverse effects can be increased when butorphanol is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Rufinamide is combined with brimonidine.


The risk or severity of adverse effects can be increased when dibucaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Articaine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Uramustine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with thalidomide.


The risk or severity of adverse effects can be increased when Telmisartan is combined with leflunomide.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when methadone is combined with tetracaine.


The risk or severity of adverse effects can be increased when Pirlindole is combined with dobutamine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with protriptyline.


The risk or severity of adverse effects can be increased when tolmetin is combined with niflumic acid.


The risk or severity of adverse effects can be increased when methylergonovine is combined with mequitazine.


The risk or severity of adverse effects can be increased when diazepam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with butalbital.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with tizanidine.


The risk or severity of adverse effects can be increased when diazepam is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with furosemide.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Icatibant.


The risk or severity of adverse effects can be increased when Toloxatone is combined with oxycodone.


The risk or severity of adverse effects can be increased when Toloxatone is combined with buspirone.


The risk or severity of adverse effects can be increased when halcinonide is combined with enoxacin.


The risk or severity of adverse effects can be increased when meprobamate is combined with Normethadone.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Remoxipride is combined with amitriptyline.


The risk or severity of adverse effects can be increased when carprofen is combined with niflumic acid.


The risk or severity of adverse effects can be increased when cilnidipine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Sacubitril.


The risk or severity of adverse effects can be increased when methadone is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when diflunisal is combined with amcinonide.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when methadone is combined with amisulpride.


The risk or severity of adverse effects can be increased when diflunisal is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when Arotinolol is combined with lisinopril.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Panobinostat is combined with leflunomide.


The risk or severity of adverse effects can be increased when Arotinolol is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Carbetocin is combined with furosemide.


The risk or severity of adverse effects can be increased when Carbetocin is combined with tizanidine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Carbetocin is combined with phentolamine.


The risk or severity of adverse effects can be increased when simvastatin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with Sacubitril.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with amisulpride.


The risk or severity of adverse effects can be increased when oxazepam is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when cocaine is combined with tizanidine.


The risk or severity of adverse effects can be increased when amoxapine is combined with ritodrine.


The risk or severity of adverse effects can be increased when oxycodone is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Ephedrine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when Ephedrine is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when imipramine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when mefloquine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with meperidine.


The risk or severity of adverse effects can be increased when hexetidine is combined with isradipine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when nisoldipine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when enflurane is combined with doxepin.


The risk or severity of adverse effects can be increased when doxazosin is combined with indapamide.


The risk or severity of adverse effects can be increased when benzphetamine is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with loratadine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with prazosin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with citalopram.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with imipramine.


The risk or severity of adverse effects can be increased when Lomitapide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when methysergide is combined with topotecan.


The risk or severity of adverse effects can be increased when quazepam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when quazepam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with Triflusal.


The risk or severity of adverse effects can be increased when indomethacin is combined with medrysone.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with Ticagrelor.


The risk or severity of adverse effects can be increased when Tapentadol is combined with methylene blue.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when lorazepam is combined with thiamylal.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with clomiphene.


The risk or severity of adverse effects can be increased when hydromorphone is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with codeine.


The risk or severity of adverse effects can be increased when barnidipine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with meperidine.


The risk or severity of adverse effects can be increased when tetracaine is combined with butalbital.


The risk or severity of adverse effects can be increased when hydromorphone is combined with prazepam.


The risk or severity of adverse effects can be increased when lorazepam is combined with halothane.


The risk or severity of adverse effects can be increased when antipyrine is combined with Mometasone.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with metoclopramide.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with Eplerenone.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with methazolamide.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when tolmetin is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when Pipamperone is combined with nifedipine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when pimozide is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when linezolid is combined with naratriptan.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with carvedilol.


The risk or severity of adverse effects can be increased when Pipamperone is combined with papaverine.


The risk or severity of adverse effects can be increased when Desloratadine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when alprazolam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when zaleplon is combined with Desloratadine.


The risk or severity of adverse effects can be increased when proparacaine is combined with trimipramine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when salicylamide is combined with Propacetamol.


The risk or severity of adverse effects can be increased when scopolamine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Masoprocol is combined with fenoprofen.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Escitalopram.


The risk or severity of adverse effects can be increased when rescinnamine is combined with salicylamide.


The risk or severity of adverse effects can be increased when felodipine is combined with nifedipine.


The risk or severity of adverse effects can be increased when suprofen is combined with Mometasone.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with propoxyphene.


The risk or severity of adverse effects can be increased when trimipramine is combined with promethazine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with topotecan.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Elbasvir.


The risk or severity of adverse effects can be increased when clidinium is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when levorphanol is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when protriptyline is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when bromazepam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when diflunisal is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when nisoldipine is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Metipranolol is combined with quetiapine.


The risk or severity of adverse effects can be increased when levorphanol is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with etoposide.


The risk or severity of adverse effects can be increased when Propacetamol is combined with triamcinolone.


The risk or severity of adverse effects can be increased when efavirenz is combined with clonazepam.


The risk or severity of adverse effects can be increased when protriptyline is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when naratriptan is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with linezolid.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when trimipramine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when propoxyphene is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when ipratropium is combined with methscopolamine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when butamben is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when difluprednate is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when zaleplon is combined with estazolam.


The risk or severity of adverse effects can be increased when thiamylal is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Spirapril is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when Butethal is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Normethadone.


The risk or severity of adverse effects can be increased when diazepam is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when Masoprocol is combined with budesonide.


The risk or severity of adverse effects can be increased when butamben is combined with methocarbamol.


The risk or severity of adverse effects can be increased when tolazoline is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when lorazepam is combined with Melatonin.


The risk or severity of adverse effects can be increased when nicergoline is combined with pimozide.


The risk or severity of adverse effects can be increased when tolazoline is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when isoflurane is combined with zotepine.


The risk or severity of adverse effects can be increased when furosemide is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when betaxolol is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when zaleplon is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when pentazocine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when tacrolimus is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when RUCAPARIB is combined with oxycodone.


The risk or severity of adverse effects can be increased when propofol is combined with papaverine.


The risk or severity of adverse effects can be increased when resveratrol is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when Carbetocin is combined with irbesartan.


The risk or severity of adverse effects can be increased when resveratrol is combined with formestane.


The risk or severity of adverse effects can be increased when Masoprocol is combined with alclometasone.


The risk or severity of adverse effects can be increased when vigabatrin is combined with Escitalopram.


The risk or severity of adverse effects can be increased when mirtazapine is combined with terbutaline.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when fosinopril is combined with alclofenac.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with levodopa.


The risk or severity of adverse effects can be increased when sumatriptan is combined with quetiapine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Normethadone.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with butamben.


The risk or severity of adverse effects can be increased when thiothixene is combined with tizanidine.


The risk or severity of adverse effects can be increased when anagrelide is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when PHENPROCOUMON is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when triamterene is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when meprobamate is combined with haloperidol.


The risk or severity of adverse effects can be increased when codeine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with zotepine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with ramipril.


The risk or severity of adverse effects can be increased when Nilotinib is combined with oxycodone.


The risk or severity of adverse effects can be increased when tiapride is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Clofarabine is combined with valsartan.


The risk or severity of adverse effects can be increased when Normethadone is combined with dantrolene.


The risk or severity of adverse effects can be increased when bumetanide is combined with Spectinomycin.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with pimozide.


The risk or severity of adverse effects can be increased when dyclonine is combined with Articaine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Olopatadine.


The risk or severity of adverse effects can be increased when aspirin is combined with antipyrine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with tiapride.


The risk or severity of adverse effects can be increased when cilnidipine is combined with acebutolol.


The risk or severity of adverse effects can be increased when clorazepate is combined with Retigabine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with captopril.


The risk or severity of adverse effects can be increased when tolmetin is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when indomethacin is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when CALCIUM CHLORIDE is combined with ceftriaxone.


The risk or severity of adverse effects can be increased when DESONIDE is combined with Deferasirox.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when rasagiline is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when carbamazepine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Lurasidone.


The risk or severity of adverse effects can be increased when thiothixene is combined with cetirizine.


The risk or severity of adverse effects can be increased when thiothixene is combined with protriptyline.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with captopril.


The risk or severity of adverse effects can be increased when lidocaine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with hydromorphone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with triamterene.


The risk or severity of adverse effects can be increased when enalapril is combined with fenoprofen.


The risk or severity of adverse effects can be increased when reserpine is combined with meclizine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with furosemide.


The risk or severity of adverse effects can be increased when reserpine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with tiapride.


The risk or severity of adverse effects can be increased when Bortezomib is combined with phentolamine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sulfaphenazole.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Etidocaine.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when procyclidine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when imipramine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when fosinopril is combined with nimesulide.


The risk or severity of adverse effects can be increased when diflunisal is combined with dorzolamide.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Paliperidone is combined with dibucaine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with butamben.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with amcinonide.


The risk or severity of adverse effects can be increased when propofol is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with codeine.


The risk or severity of adverse effects can be increased when reserpine is combined with bromazepam.


The risk or severity of adverse effects can be increased when propofol is combined with Metipranolol.


The risk or severity of adverse effects can be increased when hydromorphone is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when hydromorphone is combined with triazolam.


The risk or severity of adverse effects can be increased when Rivaroxaban is combined with meperidine.


The risk or severity of adverse effects can be increased when thioridazine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when dyclonine is combined with etizolam.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when enalapril is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when glyburide is combined with Carbocisteine.


The risk or severity of adverse effects can be increased when dibucaine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Bortezomib is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when enalapril is combined with Droxicam.


The risk or severity of adverse effects can be increased when enalapril is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when dibucaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when HEROIN is combined with Pipamperone.


The risk or severity of adverse effects can be increased when enalapril is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when propantheline is combined with DIPHENOXYLATE.